

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 8.03359974 |
| 2 | central nervous system myelination (GO:0022010) | 8.03359974 |
| 3 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 7.85946905 |
| 4 | L-amino acid import (GO:0043092) | 5.08890550 |
| 5 | * ensheathment of neurons (GO:0007272) | 5.08365702 |
| 6 | * axon ensheathment (GO:0008366) | 5.08365702 |
| 7 | * myelination (GO:0042552) | 5.06701763 |
| 8 | synaptic vesicle maturation (GO:0016188) | 4.88358459 |
| 9 | neuronal action potential propagation (GO:0019227) | 4.75187741 |
| 10 | fatty acid elongation (GO:0030497) | 4.63296260 |
| 11 | locomotory exploration behavior (GO:0035641) | 4.59075102 |
| 12 | positive regulation of synapse maturation (GO:0090129) | 4.30066660 |
| 13 | glycine transport (GO:0015816) | 4.25632240 |
| 14 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.25609487 |
| 15 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.25011903 |
| 16 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.18757854 |
| 17 | transmission of nerve impulse (GO:0019226) | 4.18179918 |
| 18 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.17020858 |
| 19 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.14401311 |
| 20 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.98626792 |
| 21 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.97384706 |
| 22 | amino acid import (GO:0043090) | 3.95397664 |
| 23 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.93949465 |
| 24 | neuronal ion channel clustering (GO:0045161) | 3.92651248 |
| 25 | regulation of ARF protein signal transduction (GO:0032012) | 3.92405289 |
| 26 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.91251957 |
| 27 | negative regulation of neurotransmitter transport (GO:0051589) | 3.89397638 |
| 28 | postsynaptic membrane organization (GO:0001941) | 3.85358835 |
| 29 | adult walking behavior (GO:0007628) | 3.81631480 |
| 30 | synaptic vesicle exocytosis (GO:0016079) | 3.79168017 |
| 31 | regulation of neurotransmitter secretion (GO:0046928) | 3.79006632 |
| 32 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.74906067 |
| 33 | gamma-aminobutyric acid transport (GO:0015812) | 3.70222668 |
| 34 | neuron cell-cell adhesion (GO:0007158) | 3.68906659 |
| 35 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.66995260 |
| 36 | positive regulation of dendritic spine development (GO:0060999) | 3.66054228 |
| 37 | cell communication by electrical coupling (GO:0010644) | 3.59780612 |
| 38 | cellular sodium ion homeostasis (GO:0006883) | 3.59141691 |
| 39 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.58517963 |
| 40 | dendritic spine morphogenesis (GO:0060997) | 3.57494639 |
| 41 | glutamate secretion (GO:0014047) | 3.55900350 |
| 42 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.55722037 |
| 43 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.54977099 |
| 44 | myelin maintenance (GO:0043217) | 3.54938890 |
| 45 | synaptic vesicle endocytosis (GO:0048488) | 3.53406540 |
| 46 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.52241178 |
| 47 | regulation of neurotransmitter transport (GO:0051588) | 3.51202563 |
| 48 | neuromuscular process controlling posture (GO:0050884) | 3.45162817 |
| 49 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.38306052 |
| 50 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.37867179 |
| 51 | regulation of synapse maturation (GO:0090128) | 3.37179954 |
| 52 | regulation of synaptic vesicle transport (GO:1902803) | 3.37096488 |
| 53 | regulation of collateral sprouting (GO:0048670) | 3.35768656 |
| 54 | presynaptic membrane organization (GO:0097090) | 3.35360934 |
| 55 | regulation of postsynaptic membrane potential (GO:0060078) | 3.34945206 |
| 56 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.33448845 |
| 57 | regulation of vesicle fusion (GO:0031338) | 3.30402759 |
| 58 | vocalization behavior (GO:0071625) | 3.30165171 |
| 59 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.27804728 |
| 60 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.25006839 |
| 61 | regulation of dendritic spine development (GO:0060998) | 3.24993116 |
| 62 | oligodendrocyte differentiation (GO:0048709) | 3.23280907 |
| 63 | positive regulation of neurotransmitter transport (GO:0051590) | 3.23239724 |
| 64 | neurotransmitter secretion (GO:0007269) | 3.23229903 |
| 65 | response to methylmercury (GO:0051597) | 3.23124646 |
| 66 | negative regulation of protein localization to cell surface (GO:2000009) | 3.22085947 |
| 67 | myelination in peripheral nervous system (GO:0022011) | 3.21534051 |
| 68 | peripheral nervous system axon ensheathment (GO:0032292) | 3.21534051 |
| 69 | neuron-neuron synaptic transmission (GO:0007270) | 3.17701477 |
| 70 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.16498585 |
| 71 | synaptic transmission, glutamatergic (GO:0035249) | 3.15686535 |
| 72 | regulation of synaptic transmission (GO:0050804) | 3.15457336 |
| 73 | exploration behavior (GO:0035640) | 3.14494581 |
| 74 | establishment of mitochondrion localization (GO:0051654) | 3.14219978 |
| 75 | cerebellar granule cell differentiation (GO:0021707) | 3.13808301 |
| 76 | presynaptic membrane assembly (GO:0097105) | 3.13518434 |
| 77 | proline transport (GO:0015824) | 3.12642105 |
| 78 | negative regulation of inclusion body assembly (GO:0090084) | 3.11716384 |
| 79 | positive regulation of Rap GTPase activity (GO:0032854) | 3.11273739 |
| 80 | cellular potassium ion homeostasis (GO:0030007) | 3.09256417 |
| 81 | glycerophospholipid catabolic process (GO:0046475) | 3.09046198 |
| 82 | neuromuscular process controlling balance (GO:0050885) | 3.05860854 |
| 83 | glutamate receptor signaling pathway (GO:0007215) | 3.05439884 |
| 84 | positive regulation of membrane potential (GO:0045838) | 3.05007689 |
| 85 | regulation of synapse structural plasticity (GO:0051823) | 3.04566422 |
| 86 | potassium ion import (GO:0010107) | 3.03448877 |
| 87 | protein localization to synapse (GO:0035418) | 3.03184755 |
| 88 | membrane depolarization during action potential (GO:0086010) | 3.02718851 |
| 89 | vesicle docking involved in exocytosis (GO:0006904) | 3.01534406 |
| 90 | membrane depolarization (GO:0051899) | 3.01338606 |
| 91 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.01130512 |
| 92 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.99986981 |
| 93 | long-term memory (GO:0007616) | 2.98363909 |
| 94 | cell differentiation in hindbrain (GO:0021533) | 2.98203427 |
| 95 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.96757725 |
| 96 | activation of protein kinase A activity (GO:0034199) | 2.96711948 |
| 97 | mating behavior (GO:0007617) | 2.96550074 |
| 98 | neurotransmitter transport (GO:0006836) | 2.94797239 |
| 99 | astrocyte development (GO:0014002) | 2.94793840 |
| 100 | dendrite morphogenesis (GO:0048813) | 2.93259627 |
| 101 | nerve growth factor signaling pathway (GO:0038180) | 2.93174392 |
| 102 | membrane hyperpolarization (GO:0060081) | 2.92935164 |
| 103 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.92676688 |
| 104 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.91639096 |
| 105 | layer formation in cerebral cortex (GO:0021819) | 2.88020598 |
| 106 | import into cell (GO:0098657) | 2.87930673 |
| 107 | neuron recognition (GO:0008038) | 2.87705121 |
| 108 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.86046435 |
| 109 | * substantia nigra development (GO:0021762) | 2.84040047 |
| 110 | neurotransmitter uptake (GO:0001504) | 2.83479485 |
| 111 | acidic amino acid transport (GO:0015800) | 2.81428201 |
| 112 | sodium ion export (GO:0071436) | 2.81056366 |
| 113 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.81017969 |
| 114 | cholesterol biosynthetic process (GO:0006695) | 2.80944276 |
| 115 | long-term synaptic potentiation (GO:0060291) | 2.80607771 |
| 116 | membrane tubulation (GO:0097320) | 2.80590489 |
| 117 | L-glutamate transport (GO:0015813) | 2.80448173 |
| 118 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.80233339 |
| 119 | creatine metabolic process (GO:0006600) | 2.77271740 |
| 120 | potassium ion homeostasis (GO:0055075) | 2.77162566 |
| 121 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.76785121 |
| 122 | * negative regulation of axonogenesis (GO:0050771) | 2.75494539 |
| 123 | regulation of synaptic plasticity (GO:0048167) | 2.75459419 |
| 124 | apical protein localization (GO:0045176) | 2.74992778 |
| 125 | negative regulation of axon extension (GO:0030517) | 2.72334776 |
| 126 | regulation of neurotransmitter levels (GO:0001505) | 2.71158181 |
| 127 | auditory behavior (GO:0031223) | 2.70326402 |
| 128 | prepulse inhibition (GO:0060134) | 2.69664953 |
| 129 | adult locomotory behavior (GO:0008344) | 2.68203913 |
| 130 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.66937770 |
| 131 | photoreceptor cell differentiation (GO:0046530) | 2.66150871 |
| 132 | eye photoreceptor cell differentiation (GO:0001754) | 2.66150871 |
| 133 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.65064703 |
| 134 | neurotransmitter catabolic process (GO:0042135) | 2.63632159 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.15999022 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.06794965 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.92783282 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.92407237 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.81169770 |
| 6 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.65396883 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.62385500 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.62385500 |
| 9 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.58410419 |
| 10 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.55758233 |
| 11 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.55102439 |
| 12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.49881801 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.39079118 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.36490133 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.32808511 |
| 16 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.31449886 |
| 17 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.30793765 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.28213857 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.27568007 |
| 20 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.27227493 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.09476832 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.07950534 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.02620258 |
| 24 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.95474453 |
| 25 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.89734051 |
| 26 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.81134447 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.80971326 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.67546181 |
| 29 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.65692471 |
| 30 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.64205086 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.60687967 |
| 32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.60234555 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.57539629 |
| 34 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.54823347 |
| 35 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.52488298 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39775284 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.39650099 |
| 38 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.38016293 |
| 39 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.31024799 |
| 40 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29879025 |
| 41 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.29869174 |
| 42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29660551 |
| 43 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.29344698 |
| 44 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.28903048 |
| 45 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27642841 |
| 46 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27509839 |
| 47 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.26983515 |
| 48 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.26671971 |
| 49 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.23551365 |
| 50 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21283433 |
| 51 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.20567403 |
| 52 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.18439621 |
| 53 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18143693 |
| 54 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.17927731 |
| 55 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.16412949 |
| 56 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.16285969 |
| 57 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.14599208 |
| 58 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.14276532 |
| 59 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12199386 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11583437 |
| 61 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09522329 |
| 62 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08747577 |
| 63 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.08676524 |
| 64 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08430555 |
| 65 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07495434 |
| 66 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.07423495 |
| 67 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07115038 |
| 68 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06469710 |
| 69 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04837574 |
| 70 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04798411 |
| 71 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.03325880 |
| 72 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.02514667 |
| 73 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01449775 |
| 74 | KDM2B_26808549_Chip-Seq_K562_Human | 1.00854973 |
| 75 | TCF4_23295773_ChIP-Seq_U87_Human | 1.00084948 |
| 76 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.99916445 |
| 77 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.99915305 |
| 78 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98879102 |
| 79 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.98596724 |
| 80 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98245988 |
| 81 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.97541199 |
| 82 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.95906529 |
| 83 | * AR_19668381_ChIP-Seq_PC3_Human | 0.95454928 |
| 84 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.94058319 |
| 85 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.93863073 |
| 86 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.92797261 |
| 87 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92462463 |
| 88 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.91056485 |
| 89 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90809600 |
| 90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90705641 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89905554 |
| 92 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.89599823 |
| 93 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.89463708 |
| 94 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.89421631 |
| 95 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.89090791 |
| 96 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.89065182 |
| 97 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88541489 |
| 98 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.88498807 |
| 99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.88434758 |
| 100 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.88034933 |
| 101 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.87427006 |
| 102 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.86183973 |
| 103 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.85952717 |
| 104 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85902286 |
| 105 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85554136 |
| 106 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.85088377 |
| 107 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84763472 |
| 108 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.84430482 |
| 109 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.84179744 |
| 110 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.83904555 |
| 111 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.83904555 |
| 112 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.83795095 |
| 113 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83538907 |
| 114 | TP53_16413492_ChIP-PET_HCT116_Human | 0.83488518 |
| 115 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.83023180 |
| 116 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82676701 |
| 117 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.82321153 |
| 118 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.81938546 |
| 119 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.81893849 |
| 120 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.81317455 |
| 121 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.80982575 |
| 122 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.80399130 |
| 123 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.80283981 |
| 124 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.79824188 |
| 125 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.79773949 |
| 126 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79033601 |
| 127 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.78448115 |
| 128 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.76893159 |
| 129 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.76640842 |
| 130 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.74432301 |
| 131 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.73383346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.19493897 |
| 2 | MP0003880_abnormal_central_pattern | 4.89390788 |
| 3 | * MP0000920_abnormal_myelination | 3.89315644 |
| 4 | MP0004270_analgesia | 3.74404317 |
| 5 | * MP0003635_abnormal_synaptic_transmissio | 3.42375129 |
| 6 | * MP0002064_seizures | 3.15218763 |
| 7 | MP0002272_abnormal_nervous_system | 3.13382157 |
| 8 | MP0009046_muscle_twitch | 3.04183591 |
| 9 | MP0001486_abnormal_startle_reflex | 2.99647089 |
| 10 | * MP0009745_abnormal_behavioral_response | 2.95332591 |
| 11 | MP0003690_abnormal_glial_cell | 2.94228735 |
| 12 | MP0002822_catalepsy | 2.86863764 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.74412699 |
| 14 | MP0003329_amyloid_beta_deposits | 2.67029439 |
| 15 | MP0004885_abnormal_endolymph | 2.63225018 |
| 16 | * MP0002063_abnormal_learning/memory/cond | 2.54610461 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.38864645 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.29606183 |
| 19 | MP0008569_lethality_at_weaning | 2.24068959 |
| 20 | MP0001529_abnormal_vocalization | 2.21908065 |
| 21 | MP0004142_abnormal_muscle_tone | 2.16729481 |
| 22 | MP0001968_abnormal_touch/_nociception | 2.11765579 |
| 23 | MP0003634_abnormal_glial_cell | 2.01583297 |
| 24 | MP0001905_abnormal_dopamine_level | 2.00720841 |
| 25 | MP0000778_abnormal_nervous_system | 1.96006208 |
| 26 | MP0001440_abnormal_grooming_behavior | 1.93430382 |
| 27 | MP0002067_abnormal_sensory_capabilities | 1.82529560 |
| 28 | MP0001970_abnormal_pain_threshold | 1.81148159 |
| 29 | MP0001501_abnormal_sleep_pattern | 1.76943108 |
| 30 | MP0000955_abnormal_spinal_cord | 1.75353828 |
| 31 | MP0001485_abnormal_pinna_reflex | 1.73864578 |
| 32 | MP0002733_abnormal_thermal_nociception | 1.73641857 |
| 33 | MP0003632_abnormal_nervous_system | 1.68065265 |
| 34 | MP0003633_abnormal_nervous_system | 1.67106906 |
| 35 | MP0002229_neurodegeneration | 1.64029211 |
| 36 | MP0004924_abnormal_behavior | 1.62465671 |
| 37 | MP0005386_behavior/neurological_phenoty | 1.62465671 |
| 38 | MP0003631_nervous_system_phenotype | 1.60887463 |
| 39 | * MP0002066_abnormal_motor_capabilities/c | 1.55498764 |
| 40 | MP0005171_absent_coat_pigmentation | 1.54548763 |
| 41 | MP0005409_darkened_coat_color | 1.53276622 |
| 42 | * MP0002882_abnormal_neuron_morphology | 1.52366394 |
| 43 | MP0002736_abnormal_nociception_after | 1.48081744 |
| 44 | * MP0004742_abnormal_vestibular_system | 1.38427272 |
| 45 | MP0000604_amyloidosis | 1.36389942 |
| 46 | * MP0004811_abnormal_neuron_physiology | 1.33230756 |
| 47 | MP0002557_abnormal_social/conspecific_i | 1.31194567 |
| 48 | MP0002735_abnormal_chemical_nociception | 1.28831382 |
| 49 | MP0002184_abnormal_innervation | 1.25270060 |
| 50 | MP0005623_abnormal_meninges_morphology | 1.22988141 |
| 51 | MP0001177_atelectasis | 1.18629970 |
| 52 | MP0005646_abnormal_pituitary_gland | 1.18157336 |
| 53 | MP0003123_paternal_imprinting | 1.17931131 |
| 54 | MP0003950_abnormal_plasma_membrane | 1.12454481 |
| 55 | MP0004145_abnormal_muscle_electrophysio | 1.11226017 |
| 56 | MP0004043_abnormal_pH_regulation | 1.11073020 |
| 57 | MP0005551_abnormal_eye_electrophysiolog | 1.10138333 |
| 58 | MP0005410_abnormal_fertilization | 1.09153952 |
| 59 | MP0009780_abnormal_chondrocyte_physiolo | 1.06589083 |
| 60 | MP0000747_muscle_weakness | 1.05089549 |
| 61 | MP0002152_abnormal_brain_morphology | 1.04438999 |
| 62 | MP0001299_abnormal_eye_distance/ | 1.03063794 |
| 63 | MP0003136_yellow_coat_color | 0.96880107 |
| 64 | MP0002752_abnormal_somatic_nervous | 0.96089436 |
| 65 | MP0003075_altered_response_to | 0.95011939 |
| 66 | MP0004858_abnormal_nervous_system | 0.94428509 |
| 67 | MP0002909_abnormal_adrenal_gland | 0.93791933 |
| 68 | MP0001502_abnormal_circadian_rhythm | 0.93726206 |
| 69 | MP0001984_abnormal_olfaction | 0.93173784 |
| 70 | * MP0001963_abnormal_hearing_physiology | 0.91558570 |
| 71 | MP0003122_maternal_imprinting | 0.89930304 |
| 72 | MP0008874_decreased_physiological_sensi | 0.85231492 |
| 73 | MP0000462_abnormal_digestive_system | 0.84747493 |
| 74 | MP0002090_abnormal_vision | 0.84746622 |
| 75 | MP0010678_abnormal_skin_adnexa | 0.82620422 |
| 76 | MP0001986_abnormal_taste_sensitivity | 0.81180905 |
| 77 | MP0005645_abnormal_hypothalamus_physiol | 0.77683742 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 0.75647518 |
| 79 | MP0000013_abnormal_adipose_tissue | 0.75622740 |
| 80 | MP0004147_increased_porphyrin_level | 0.75062676 |
| 81 | MP0001348_abnormal_lacrimal_gland | 0.74195204 |
| 82 | MP0004134_abnormal_chest_morphology | 0.73383187 |
| 83 | MP0006276_abnormal_autonomic_nervous | 0.73092677 |
| 84 | MP0002069_abnormal_eating/drinking_beha | 0.72394245 |
| 85 | MP0000751_myopathy | 0.70606871 |
| 86 | MP0003137_abnormal_impulse_conducting | 0.69566980 |
| 87 | MP0005058_abnormal_lysosome_morphology | 0.69322415 |
| 88 | MP0003172_abnormal_lysosome_physiology | 0.68495934 |
| 89 | MP0004130_abnormal_muscle_cell | 0.67561918 |
| 90 | MP0003045_fibrosis | 0.66263133 |
| 91 | MP0002638_abnormal_pupillary_reflex | 0.65765253 |
| 92 | MP0003879_abnormal_hair_cell | 0.65251607 |
| 93 | MP0008872_abnormal_physiological_respon | 0.64849778 |
| 94 | MP0005166_decreased_susceptibility_to | 0.64280950 |
| 95 | MP0000579_abnormal_nail_morphology | 0.63377955 |
| 96 | MP0000569_abnormal_digit_pigmentation | 0.61471525 |
| 97 | MP0004085_abnormal_heartbeat | 0.59654712 |
| 98 | MP0001943_abnormal_respiration | 0.57089486 |
| 99 | MP0000003_abnormal_adipose_tissue | 0.56232965 |
| 100 | MP0003787_abnormal_imprinting | 0.54590827 |
| 101 | MP0005535_abnormal_body_temperature | 0.54371644 |
| 102 | MP0001346_abnormal_lacrimal_gland | 0.51918918 |
| 103 | MP0008260_abnormal_autophagy | 0.50706610 |
| 104 | MP0005253_abnormal_eye_physiology | 0.50319340 |
| 105 | MP0010769_abnormal_survival | 0.50211587 |
| 106 | MP0003183_abnormal_peptide_metabolism | 0.50036487 |
| 107 | MP0000383_abnormal_hair_follicle | 0.49950738 |
| 108 | MP0005388_respiratory_system_phenotype | 0.49898838 |
| 109 | MP0002133_abnormal_respiratory_system | 0.49898838 |
| 110 | MP0000631_abnormal_neuroendocrine_gland | 0.49056703 |
| 111 | MP0010768_mortality/aging | 0.49017222 |
| 112 | MP0003283_abnormal_digestive_organ | 0.48676261 |
| 113 | MP0005195_abnormal_posterior_eye | 0.48673330 |
| 114 | MP0010770_preweaning_lethality | 0.47511683 |
| 115 | MP0002082_postnatal_lethality | 0.47511683 |
| 116 | MP0004510_myositis | 0.47492838 |
| 117 | MP0003956_abnormal_body_size | 0.47248108 |
| 118 | MP0000026_abnormal_inner_ear | 0.47064636 |
| 119 | MP0000566_synostosis | 0.45299608 |
| 120 | MP0010386_abnormal_urinary_bladder | 0.43941565 |
| 121 | MP0000639_abnormal_adrenal_gland | 0.41705723 |
| 122 | MP0008877_abnormal_DNA_methylation | 0.41265723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.00552741 |
| 2 | Neurofibrillary tangles (HP:0002185) | 5.20507358 |
| 3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.04754198 |
| 4 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.04754198 |
| 5 | Peripheral hypomyelination (HP:0007182) | 4.85645688 |
| 6 | Focal motor seizures (HP:0011153) | 4.85615909 |
| 7 | Supranuclear gaze palsy (HP:0000605) | 4.78866846 |
| 8 | Action tremor (HP:0002345) | 4.56348192 |
| 9 | Abnormality of the corticospinal tract (HP:0002492) | 4.30534621 |
| 10 | Intention tremor (HP:0002080) | 4.15576574 |
| 11 | Ankle clonus (HP:0011448) | 4.06209613 |
| 12 | Dysmetria (HP:0001310) | 4.03217186 |
| 13 | Termporal pattern (HP:0011008) | 4.00661406 |
| 14 | Insidious onset (HP:0003587) | 4.00661406 |
| 15 | Spastic gait (HP:0002064) | 3.99210059 |
| 16 | Onion bulb formation (HP:0003383) | 3.89863975 |
| 17 | Cerebral inclusion bodies (HP:0100314) | 3.89723657 |
| 18 | Focal seizures (HP:0007359) | 3.80907740 |
| 19 | Scanning speech (HP:0002168) | 3.68812270 |
| 20 | Sensory axonal neuropathy (HP:0003390) | 3.68396208 |
| 21 | Atonic seizures (HP:0010819) | 3.60089494 |
| 22 | Cerebral hypomyelination (HP:0006808) | 3.52354136 |
| 23 | Papilledema (HP:0001085) | 3.48568238 |
| 24 | Obstructive sleep apnea (HP:0002870) | 3.44711201 |
| 25 | Hemiplegia (HP:0002301) | 3.23773741 |
| 26 | Tetraplegia (HP:0002445) | 3.23305111 |
| 27 | Annular pancreas (HP:0001734) | 3.12522875 |
| 28 | Progressive cerebellar ataxia (HP:0002073) | 3.06362569 |
| 29 | Visual hallucinations (HP:0002367) | 3.04495423 |
| 30 | Slow saccadic eye movements (HP:0000514) | 2.96337061 |
| 31 | Dysdiadochokinesis (HP:0002075) | 2.94374043 |
| 32 | Epileptic encephalopathy (HP:0200134) | 2.88153060 |
| 33 | Urinary urgency (HP:0000012) | 2.87501114 |
| 34 | Abnormal auditory evoked potentials (HP:0006958) | 2.87418522 |
| 35 | Delusions (HP:0000746) | 2.81215696 |
| 36 | Increased circulating renin level (HP:0000848) | 2.73920227 |
| 37 | Megalencephaly (HP:0001355) | 2.73648117 |
| 38 | Bradykinesia (HP:0002067) | 2.70511869 |
| 39 | Postural instability (HP:0002172) | 2.68840744 |
| 40 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.67770665 |
| 41 | Akinesia (HP:0002304) | 2.65614035 |
| 42 | Lower limb muscle weakness (HP:0007340) | 2.64345995 |
| 43 | Pheochromocytoma (HP:0002666) | 2.64221713 |
| 44 | Parakeratosis (HP:0001036) | 2.63468486 |
| 45 | Gaze-evoked nystagmus (HP:0000640) | 2.62010765 |
| 46 | Apathy (HP:0000741) | 2.61691605 |
| 47 | Status epilepticus (HP:0002133) | 2.60931937 |
| 48 | Clonus (HP:0002169) | 2.60731532 |
| 49 | Anxiety (HP:0000739) | 2.55654785 |
| 50 | Insomnia (HP:0100785) | 2.54895827 |
| 51 | Alacrima (HP:0000522) | 2.52990083 |
| 52 | Dialeptic seizures (HP:0011146) | 2.52972654 |
| 53 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.51624196 |
| 54 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.47240407 |
| 55 | Rapidly progressive (HP:0003678) | 2.46869298 |
| 56 | Sleep apnea (HP:0010535) | 2.45622844 |
| 57 | Generalized tonic-clonic seizures (HP:0002069) | 2.45581774 |
| 58 | Absence seizures (HP:0002121) | 2.44768926 |
| 59 | Depression (HP:0000716) | 2.44166095 |
| 60 | Torticollis (HP:0000473) | 2.42230286 |
| 61 | Broad-based gait (HP:0002136) | 2.42130666 |
| 62 | Abnormal eating behavior (HP:0100738) | 2.40839176 |
| 63 | Diminished motivation (HP:0000745) | 2.34870451 |
| 64 | Hammertoe (HP:0001765) | 2.34646319 |
| 65 | Retinal dysplasia (HP:0007973) | 2.34522048 |
| 66 | Abnormality of saccadic eye movements (HP:0000570) | 2.33543088 |
| 67 | Epileptiform EEG discharges (HP:0011182) | 2.31892554 |
| 68 | Abnormality of the periventricular white matter (HP:0002518) | 2.31690118 |
| 69 | Bundle branch block (HP:0011710) | 2.28446606 |
| 70 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.27305786 |
| 71 | Aplasia of the phalanges of the hand (HP:0009802) | 2.27305786 |
| 72 | Aplasia involving bones of the extremities (HP:0009825) | 2.27305786 |
| 73 | Truncal ataxia (HP:0002078) | 2.25841242 |
| 74 | Impaired smooth pursuit (HP:0007772) | 2.25840942 |
| 75 | CNS hypomyelination (HP:0003429) | 2.25150886 |
| 76 | Neuroendocrine neoplasm (HP:0100634) | 2.23169534 |
| 77 | Spastic tetraparesis (HP:0001285) | 2.19857824 |
| 78 | Mutism (HP:0002300) | 2.16553487 |
| 79 | Leukodystrophy (HP:0002415) | 2.16007175 |
| 80 | Febrile seizures (HP:0002373) | 2.13535388 |
| 81 | Morphological abnormality of the inner ear (HP:0011390) | 2.13254301 |
| 82 | Abnormality of the lower motor neuron (HP:0002366) | 2.12987933 |
| 83 | Focal dystonia (HP:0004373) | 2.12425182 |
| 84 | Postural tremor (HP:0002174) | 2.11281141 |
| 85 | Poor eye contact (HP:0000817) | 2.10452501 |
| 86 | Memory impairment (HP:0002354) | 2.10368901 |
| 87 | Decreased motor nerve conduction velocity (HP:0003431) | 2.09121002 |
| 88 | Neuronal loss in central nervous system (HP:0002529) | 2.08072568 |
| 89 | Cerebral hemorrhage (HP:0001342) | 2.07613511 |
| 90 | Impaired vibratory sensation (HP:0002495) | 2.07589093 |
| 91 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.07578029 |
| 92 | Foot dorsiflexor weakness (HP:0009027) | 2.07228875 |
| 93 | Generalized myoclonic seizures (HP:0002123) | 2.07065814 |
| 94 | Clumsiness (HP:0002312) | 2.06492028 |
| 95 | Distal sensory impairment (HP:0002936) | 2.06260408 |
| 96 | Limb dystonia (HP:0002451) | 2.06050028 |
| 97 | Stridor (HP:0010307) | 2.05279902 |
| 98 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.04158355 |
| 99 | Craniofacial dystonia (HP:0012179) | 2.03858072 |
| 100 | Progressive inability to walk (HP:0002505) | 2.03322422 |
| 101 | Metabolic alkalosis (HP:0200114) | 2.03051241 |
| 102 | Stereotypic behavior (HP:0000733) | 2.01039753 |
| 103 | Thickened helices (HP:0000391) | 2.00421771 |
| 104 | Ulnar claw (HP:0001178) | 1.99917204 |
| 105 | Abnormal social behavior (HP:0012433) | 1.98709917 |
| 106 | Impaired social interactions (HP:0000735) | 1.98709917 |
| 107 | EEG with generalized epileptiform discharges (HP:0011198) | 1.98669605 |
| 108 | Hemiparesis (HP:0001269) | 1.98515441 |
| 109 | Choreoathetosis (HP:0001266) | 1.98247547 |
| 110 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.97862800 |
| 111 | Bowel incontinence (HP:0002607) | 1.97102534 |
| 112 | Lower limb amyotrophy (HP:0007210) | 1.94902793 |
| 113 | Decreased lacrimation (HP:0000633) | 1.93586853 |
| 114 | Spastic paraparesis (HP:0002313) | 1.93564834 |
| 115 | Amblyopia (HP:0000646) | 1.93193658 |
| 116 | Ventricular fibrillation (HP:0001663) | 1.92318536 |
| 117 | Steppage gait (HP:0003376) | 1.92232470 |
| 118 | Ocular albinism (HP:0001107) | 1.91922552 |
| 119 | Rigidity (HP:0002063) | 1.91675422 |
| 120 | Spastic paraplegia (HP:0001258) | 1.90985428 |
| 121 | Hypomagnesemia (HP:0002917) | 1.90361292 |
| 122 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.90200280 |
| 123 | Abnormality of binocular vision (HP:0011514) | 1.88750036 |
| 124 | Diplopia (HP:0000651) | 1.88750036 |
| 125 | Slow progression (HP:0003677) | 1.88662284 |
| 126 | Abnormality of the foot musculature (HP:0001436) | 1.88017797 |
| 127 | Paraplegia (HP:0010550) | 1.85981067 |
| 128 | Split foot (HP:0001839) | 1.84057256 |
| 129 | Hypsarrhythmia (HP:0002521) | 1.83019155 |
| 130 | Fetal akinesia sequence (HP:0001989) | 1.81921707 |
| 131 | Iris hypopigmentation (HP:0007730) | 1.81673439 |
| 132 | Abnormal large intestine physiology (HP:0012700) | 1.80767078 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.41725679 |
| 2 | EPHA4 | 3.39496664 |
| 3 | OXSR1 | 3.37858394 |
| 4 | TNIK | 2.77123789 |
| 5 | CDK19 | 2.43545378 |
| 6 | NTRK3 | 2.40240198 |
| 7 | EPHB1 | 2.40117667 |
| 8 | WNK1 | 2.30707648 |
| 9 | MAP3K9 | 2.28532328 |
| 10 | PAK6 | 2.25985120 |
| 11 | NTRK1 | 2.14608806 |
| 12 | PRPF4B | 1.99350818 |
| 13 | TYRO3 | 1.96332810 |
| 14 | * UHMK1 | 1.84234138 |
| 15 | PKN1 | 1.83643460 |
| 16 | WNK4 | 1.81497083 |
| 17 | KSR2 | 1.80903933 |
| 18 | PRKD3 | 1.78744973 |
| 19 | MAPKAPK5 | 1.78523707 |
| 20 | MINK1 | 1.76964541 |
| 21 | BCR | 1.74448240 |
| 22 | MARK1 | 1.69559578 |
| 23 | NEK6 | 1.65929359 |
| 24 | RIPK1 | 1.63855879 |
| 25 | MAP3K4 | 1.53437463 |
| 26 | FGFR2 | 1.52247614 |
| 27 | LIMK1 | 1.46416656 |
| 28 | SGK494 | 1.44694867 |
| 29 | SGK223 | 1.44694867 |
| 30 | NTRK2 | 1.43969217 |
| 31 | CDK5 | 1.41419164 |
| 32 | FES | 1.37275180 |
| 33 | LATS2 | 1.36006890 |
| 34 | PINK1 | 1.34826807 |
| 35 | CAMK2B | 1.34191296 |
| 36 | ICK | 1.32099988 |
| 37 | ROCK2 | 1.31618781 |
| 38 | PNCK | 1.25589407 |
| 39 | ARAF | 1.25536774 |
| 40 | CAMKK1 | 1.23497876 |
| 41 | DAPK1 | 1.23314583 |
| 42 | DAPK2 | 1.15039710 |
| 43 | MAP3K2 | 1.14301805 |
| 44 | SIK2 | 1.11867755 |
| 45 | CSNK1G2 | 1.08973588 |
| 46 | CAMK2D | 1.08503014 |
| 47 | SGK2 | 1.07777220 |
| 48 | MAP3K13 | 1.07674783 |
| 49 | CSNK1G3 | 1.07437828 |
| 50 | MAPK13 | 1.05355114 |
| 51 | CDK14 | 1.05348634 |
| 52 | MAP2K7 | 1.04475380 |
| 53 | CSNK1A1L | 1.02419894 |
| 54 | MET | 1.01972823 |
| 55 | CDK15 | 1.01037689 |
| 56 | MAPK12 | 1.00143931 |
| 57 | SGK3 | 1.00017380 |
| 58 | PRKCH | 0.98143844 |
| 59 | CDK18 | 0.96267594 |
| 60 | CAMK2G | 0.95583993 |
| 61 | MARK2 | 0.92053661 |
| 62 | FGR | 0.91154659 |
| 63 | CDK11A | 0.89921108 |
| 64 | CAMK2A | 0.89555228 |
| 65 | PDPK1 | 0.88535359 |
| 66 | PAK3 | 0.85873330 |
| 67 | PHKG2 | 0.85788781 |
| 68 | PHKG1 | 0.85788781 |
| 69 | STK11 | 0.85167632 |
| 70 | IRAK2 | 0.84396611 |
| 71 | GRK5 | 0.78521976 |
| 72 | MAP2K4 | 0.77859170 |
| 73 | PBK | 0.77664798 |
| 74 | MAP3K11 | 0.77268989 |
| 75 | CAMKK2 | 0.76312456 |
| 76 | RIPK4 | 0.76210605 |
| 77 | CLK1 | 0.73962505 |
| 78 | BRSK1 | 0.71073582 |
| 79 | PRKCG | 0.70745887 |
| 80 | CSNK1G1 | 0.70278766 |
| 81 | FYN | 0.70016471 |
| 82 | DAPK3 | 0.68304397 |
| 83 | PDK1 | 0.67838442 |
| 84 | ALK | 0.67568224 |
| 85 | PRKCQ | 0.67298140 |
| 86 | CAMK4 | 0.64339654 |
| 87 | STK38 | 0.62852667 |
| 88 | RET | 0.62746263 |
| 89 | PLK2 | 0.61255368 |
| 90 | CASK | 0.60514294 |
| 91 | TESK2 | 0.58750387 |
| 92 | MUSK | 0.57699003 |
| 93 | LMTK2 | 0.55997462 |
| 94 | PRKCE | 0.55459667 |
| 95 | CAMK1 | 0.53479118 |
| 96 | TNK2 | 0.52509587 |
| 97 | RAF1 | 0.52148097 |
| 98 | BRAF | 0.51418860 |
| 99 | MAPK10 | 0.50142087 |
| 100 | KSR1 | 0.50086795 |
| 101 | MAP3K1 | 0.49977080 |
| 102 | PRKCZ | 0.49856758 |
| 103 | SGK1 | 0.49193069 |
| 104 | ROCK1 | 0.48010893 |
| 105 | BMX | 0.45692100 |
| 106 | JAK2 | 0.45386354 |
| 107 | JAK1 | 0.42522815 |
| 108 | DMPK | 0.42108430 |
| 109 | RPS6KA3 | 0.41301855 |
| 110 | CSNK1A1 | 0.40572605 |
| 111 | PTK2B | 0.38712165 |
| 112 | BMPR2 | 0.38497068 |
| 113 | DYRK1A | 0.36465062 |
| 114 | PRKG1 | 0.35479822 |
| 115 | PDGFRB | 0.34994985 |
| 116 | CAMK1G | 0.34383855 |
| 117 | PRKACB | 0.33604728 |
| 118 | ERBB2 | 0.33299452 |
| 119 | PRKG2 | 0.31934795 |
| 120 | SRC | 0.31190519 |
| 121 | * PRKCA | 0.30596634 |
| 122 | PRKCB | 0.28832465 |
| 123 | CSNK1D | 0.23928430 |
| 124 | MAPK8 | 0.23640437 |
| 125 | MAPK4 | 0.23427165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.26514339 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.61501396 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.57095690 |
| 4 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.48686558 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.46556318 |
| 6 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.38895535 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.22553585 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.18448602 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.17972428 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.13069994 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.02456554 |
| 12 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.00338019 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.92688720 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 1.86269711 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 1.79608561 |
| 16 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.79404693 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.76799003 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.71900359 |
| 19 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.70276602 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.69829492 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.68769961 |
| 22 | Axon guidance_Homo sapiens_hsa04360 | 1.64208256 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.62456249 |
| 24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.59445012 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.52388757 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.50373952 |
| 27 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.47923396 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.46542559 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.43330386 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.31546162 |
| 31 | Insulin secretion_Homo sapiens_hsa04911 | 1.30554218 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.27874222 |
| 33 | Renin secretion_Homo sapiens_hsa04924 | 1.23179235 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.21307363 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 1.18535983 |
| 36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.18457974 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.17169373 |
| 38 | Taste transduction_Homo sapiens_hsa04742 | 1.16714530 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.16235074 |
| 40 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.15689832 |
| 41 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.08231630 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.07169496 |
| 43 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.06341527 |
| 44 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.05796499 |
| 45 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.05570874 |
| 46 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.02806552 |
| 47 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.02049198 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.99240889 |
| 49 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.98186108 |
| 50 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.96578646 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.94923526 |
| 52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94694187 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93780604 |
| 54 | Endocytosis_Homo sapiens_hsa04144 | 0.93654082 |
| 55 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.92911651 |
| 56 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.92564919 |
| 57 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.92477533 |
| 58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91575576 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.91233409 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89184579 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89161403 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86550064 |
| 63 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.86016785 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86013048 |
| 65 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81180859 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.80667163 |
| 67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.79025655 |
| 68 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75381575 |
| 69 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.73713026 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73338966 |
| 71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72369296 |
| 72 | Tight junction_Homo sapiens_hsa04530 | 0.69552101 |
| 73 | Alzheimers disease_Homo sapiens_hsa05010 | 0.67084114 |
| 74 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.65684968 |
| 75 | Melanogenesis_Homo sapiens_hsa04916 | 0.64676535 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.63181057 |
| 77 | Glioma_Homo sapiens_hsa05214 | 0.63126218 |
| 78 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62928236 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.62499146 |
| 80 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61374961 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60911937 |
| 82 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.60127241 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.59901521 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59494545 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58438425 |
| 86 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56167418 |
| 87 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.55602092 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54990144 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51518950 |
| 90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50956976 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.50361845 |
| 92 | Phototransduction_Homo sapiens_hsa04744 | 0.50215398 |
| 93 | Parkinsons disease_Homo sapiens_hsa05012 | 0.50142014 |
| 94 | Bile secretion_Homo sapiens_hsa04976 | 0.49899969 |
| 95 | Alcoholism_Homo sapiens_hsa05034 | 0.48443957 |
| 96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46392771 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45921391 |
| 98 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.45560814 |
| 99 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44480726 |
| 100 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44424267 |
| 101 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43430317 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | 0.42443821 |
| 103 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.41506520 |
| 104 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39979904 |
| 105 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.38816256 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38409286 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38252962 |
| 108 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38207726 |
| 109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37887064 |
| 110 | Lysosome_Homo sapiens_hsa04142 | 0.37547219 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36590945 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32955860 |
| 113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32684242 |
| 114 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.30235792 |
| 115 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29373317 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.28414992 |
| 117 | Endometrial cancer_Homo sapiens_hsa05213 | 0.28343695 |
| 118 | ABC transporters_Homo sapiens_hsa02010 | 0.28270480 |
| 119 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.28098873 |
| 120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27359859 |
| 121 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.25590381 |
| 122 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.25305005 |
| 123 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.24242556 |

